Common use

Abiraterone is an oral cancer treatment medication specifically developed for the management of metastatic castration-resistant prostate cancer (mCRPC) and metastatic high-risk castration-sensitive prostate cancer. As a CYP17 inhibitor, abiraterone works by blocking the enzyme CYP17A1, which is essential for androgen (male hormone) production in the testes, adrenal glands, and within the prostate tumor itself. By acting as an androgen synthesis blocker, abiraterone dramatically reduces testosterone levels — the primary hormone that fuels prostate cancer growth and progression.

This Zytiga generic is a cornerstone of modern hormone therapy for advanced prostate cancer, helping to slow disease progression, reduce tumor burden, and significantly improve overall survival outcomes. When you buy Abiraterone online, you receive a clinically proven cancer treatment that has demonstrated substantial benefits in large-scale clinical trials for both pre-chemotherapy and post-chemotherapy settings. Abiraterone is typically prescribed in combination with a corticosteroid such as prednisone or prednisolone to manage the side effects of adrenal hormone suppression and optimize treatment tolerability. This combination approach represents one of the most effective available hormone therapy strategies for metastatic prostate cancer.

Dosage and direction

Abiraterone is typically taken once daily on an empty stomach — at least one hour before eating or two hours after a meal. Taking this CYP17 inhibitor with food significantly increases its absorption, which can lead to elevated blood levels, greater systemic exposure, and an increased risk of serious side effects and toxicity. It must be taken concurrently with low-dose prednisone (typically 5 mg twice daily) as directed by your oncologist to reduce the risk of mineralocorticoid-related side effects associated with adrenal hormone suppression.

The standard dose for prostate cancer treatment is 1,000 mg (two 500 mg tablets or four 250 mg tablets) once daily. Your oncologist may adjust the dosage based on your individual response, liver function, and overall tolerance. Always follow your oncologist's specific instructions exactly and do not alter the dose without consulting your doctor. Consistent daily dosing is essential for maintaining therapeutic drug levels and maximizing the effectiveness of this androgen synthesis blocker against metastatic prostate cancer.

Precautions

Before starting abiraterone, inform your oncologist of any history of heart disease, liver problems, hypertension, diabetes, or adrenal insufficiency. Because this hormone therapy can significantly affect electrolyte balance, liver function, and blood pressure, regular and ongoing monitoring is essential. Your doctor will schedule frequent blood tests to check liver enzymes (ALT, AST, bilirubin), potassium levels, and blood pressure throughout the course of treatment.

Women, especially those who are pregnant or may become pregnant, should avoid handling crushed or broken abiraterone tablets, as the active ingredient can be absorbed through the skin and may cause harm to a developing fetus. This Zytiga generic is indicated exclusively for male patients with prostate cancer. Patients should maintain adequate hydration and follow a low-sodium, low-fat diet if advised by their healthcare team. Any signs of adrenal insufficiency — such as unusual fatigue, muscle weakness, dizziness upon standing, nausea, or darkening of the skin — should be reported to your oncologist promptly.

Contraindications

Abiraterone is contraindicated in individuals with severe hepatic (liver) impairment (Child-Pugh Class C), as the drug is primarily metabolized by the liver and can cause further liver damage. It must not be used by patients with a known allergy to abiraterone acetate or any of its excipients. This CYP17 inhibitor is not approved for use in women or children — it is exclusively a prostate cancer treatment for adult male patients.

Concurrent use with strong CYP3A4 enzyme inducers (such as rifampin, phenytoin, carbamazepine, and phenobarbital) should be avoided, as these drugs can significantly reduce abiraterone blood levels and diminish its cancer-fighting effectiveness. The drug must not be taken with food, as this dramatically increases systemic exposure and the risk of toxicity. Discuss all potential contraindications with your oncologist before you buy Abiraterone online for metastatic prostate cancer treatment.

Possible side effect

Common side effects of abiraterone include joint pain or swelling, fluid retention (peripheral edema), muscle discomfort, high blood pressure (hypertension), low blood potassium (hypokalemia), hot flashes, and urinary tract infections. Liver function abnormalities are frequently observed during treatment with this androgen synthesis blocker and require periodic laboratory monitoring — your oncologist will schedule regular liver enzyme blood tests.

Fatigue is one of the most commonly reported effects of this hormone therapy, affecting daily energy levels and quality of life. Serious but less common adverse effects include adrenal insufficiency (symptoms: extreme fatigue, weakness, dizziness, nausea), cardiac arrhythmias, significant liver toxicity (indicated by jaundice, dark urine, severe abdominal pain), and allergic reactions. Seek immediate medical attention if you experience any signs of liver problems, heart rhythm changes, or severe adrenal suppression while taking this Zytiga generic cancer treatment.

Drug interaction

Abiraterone is both a substrate and an inhibitor of several important cytochrome P450 enzymes and may interact with medications metabolized by CYP3A4, CYP2D6, and CYP2C8 pathways, potentially altering their blood levels, effectiveness, or toxicity. Particular caution is required when co-administering abiraterone with medications such as warfarin (increased bleeding risk), certain antidepressants (SSRIs metabolized by CYP2D6), beta-blockers (metoprolol), opioid analgesics (codeine — reduced activation), and antiepileptic drugs.

Strong CYP3A4 inducers, including rifampin, phenytoin, carbamazepine, and St. John's wort, can significantly reduce abiraterone blood levels and compromise the effectiveness of this prostate cancer treatment. Conversely, strong CYP3A4 inhibitors may increase abiraterone levels. Always provide your oncologist and pharmacist with a complete and up-to-date list of all medications, supplements, and herbal products you are taking before you buy Abiraterone online or start any new treatment alongside this CYP17 inhibitor.

Missed dose

If you miss a dose of abiraterone, take it as soon as you remember on the same day, maintaining the empty-stomach requirement. If an entire day has passed, skip the missed dose and take your regular dose the following day at the scheduled time. Do not take extra tablets to make up for a missed dose. Maintaining a consistent daily schedule is important for ensuring therapeutic drug levels and maximizing the effectiveness of this androgen synthesis blocker against metastatic prostate cancer.

Overdose

Overdose of abiraterone may lead to symptoms such as significantly elevated blood pressure, dangerously low potassium levels (hypokalemia with muscle cramps, weakness, and cardiac risks), and liver toxicity (elevated liver enzymes, jaundice). In case of suspected overdose, seek immediate emergency medical attention. There is no specific antidote for abiraterone; treatment is supportive and symptom-based, focusing on blood pressure management, electrolyte correction, and liver function monitoring. Do not exceed the prescribed dosage of this cancer treatment under any circumstances.

Storage

Store abiraterone at room temperature between 68-77 degrees F (20-25 degrees C), away from moisture, heat, and direct sunlight. Keep the tablets in their original container, tightly closed, and out of the reach of children, pets, and anyone for whom this medication is not prescribed. Do not use after the expiration date. Dispose of unused abiraterone as instructed by your pharmacist or healthcare provider, following local hazardous medication disposal guidelines.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.